What Are the Specific Regulatory Requirements for Co-Administering These Agents in Clinical Settings?
Regulatory requirements for co-administering agents mandate rigorous clinical trials and continuous post-market surveillance to ensure patient safety and therapeutic efficacy.
HRTioJuly 20, 2025